ARTICLE | Politics & Policy
Drug price hikes would have been impossible under pending bipartisan legislation backed by White House, Democrats
January 2, 2020 10:46 PM UTC
The latest round of increases in the list prices of drugs highlights how pending bipartisan legislation could force biopharma companies to rethink their business models.
In what has become a predictable biannual event, manufacturers announced price increases on hundreds of drugs this week. The average increase was 5.8%, according to Rx Savings Solutions...